DXP Enterprises heads into the final week of September with a stock up nearly 4% on the week and shorts steadily unwinding — a quiet but consistent message from the data.
The short side has been retreating for weeks. Short interest has fallen 13% over the past month to 2.1% of the free float — a level too low to drive meaningful squeeze dynamics in either direction. The daily trend confirms the direction: borrowed shares have dropped from around 395,000 in late August to 335,000 now. With borrow availability at a historically loose 3,530% — meaning roughly 35 shares remain available for every one already lent out — there is no friction in the lending market and no sign of short sellers running into trouble covering. The ORTEX short score of 33.2 is one of the lower readings in the broader universe, reinforcing the picture of a stock that bears have largely moved on from.
Borrow cost has ticked up 36% over the past week to 0.46%, but that number deserves context. At less than half a percent annualised, it remains negligibly cheap to borrow, and the move from mid-week lows near 0.30% back to current levels looks like noise rather than a structural tightening. Options positioning is marginally more cautious — the put/call ratio at 0.52 is slightly above its 20-day average of 0.51, a z-score of just 1.1 — but that is a very modest drift rather than a defensive signal. The PCR spent most of August above 0.65 before collapsing in early September, so the current reading is actually calmer than it was six weeks ago.
The analyst picture is dated but directionally constructive. The most recent action came from Stephens & Co., which lifted its target from $160 to $220 after the August earnings release, maintaining an Overweight rating. That revision followed a remarkable print: the stock jumped around 15% on the day of its Q2 results and held most of that gain over the subsequent week. With the stock now at $192.10, the Stephens target implies roughly 14.5% upside — meaningful headroom, though the consensus mean of $200 sits closer to current levels. The ORTEX factor scores show a dividend rank at the 85th percentile and an EPS surprise rank at the 73rd, suggesting the company has built a recent track record of beating estimates. The next earnings date is November 6.
Institutional ownership tells a concentrated story. FMR (Fidelity) has built to 14.99% of shares. BlackRock holds 12.3%. Together the two largest passive and active holders control over a quarter of the float. Wellington has been trimming — it disclosed a reduction from 7.0% to 5.3% in its most recent filing — while Neuberger Berman reported a sharp increase of around 455,000 shares as of June 30. None of the 13D/G registrations carry activist intent; all are passive Schedule 13G filings. CEO David Little remains among the largest individual holders at 6.9% of shares, though his most recent disclosed activity was a gift of 50,000 shares in late July — a transfer that carries no directional signal on his outlook.
The setup for November 6 is worth tracking: the last two earnings releases produced double-digit day-one moves for DXPE, both to the upside, and the stock has added roughly 76% year-to-date. Whether the Street has adequately re-priced that earnings momentum — or is still catching up — is the question that will define the next leg.
See the live data behind this article on ORTEX.
Open DXPE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
